Six-year survival after excision of cardiac malignant lymphoma.
We report a patient with a postoperative survival period of 6 years after the surgical excision of a cardiac malignant lymphoma. A 35-year-old woman underwent total excision of the tumor arising from the left ventricular outflow tract. After the operation, she was treated with chemotherapy for 6 months. She has been doing well thereafter without any medication. To date there is no evidence of recurrence.
Takagi
M
M
Department of Cardiovascular Surgery, Nagasaki University School of Medicine, Japan.
Kugimiya
T
T
Miyahara
Y
Y
Hayashi
T
T
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D018572:Disease-Free Survival; D004317:Doxorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D006338:Heart Neoplasms / Q000188:drug therapy / Q000601:surgery*; D006801:Humans; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000188:drug therapy / Q000601:surgery*; D015649:Pentostatin / Q000008:administration & dosage; D011239:Prednisolone / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
D015649:Pentostatin; D014750:Vincristine; D005047:Etoposide; D004317:Doxorubicin; D011239:Prednisolone